OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Carla Fonseca, Miren Ettcheto, Joana Bicker, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 101998-101998
Open Access | Times Cited: 13
Carla Fonseca, Miren Ettcheto, Joana Bicker, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 101998-101998
Open Access | Times Cited: 13
Showing 13 citing articles:
Escitalopram reverses anxiety-like and despair behavior and affects endocannabinoid-related genes expression in the brain of adolescent male rats subjected to early life stress
Jonasz Dragon, Miłosz Gołyszny, Michał Zieliński, et al.
Neuroscience (2025) Vol. 567, pp. 96-108
Closed Access | Times Cited: 1
Jonasz Dragon, Miłosz Gołyszny, Michał Zieliński, et al.
Neuroscience (2025) Vol. 567, pp. 96-108
Closed Access | Times Cited: 1
Intranasal irbesartan reverts cognitive decline and activates the PI3K/AKT pathway in an LPS-induced neuroinflammation mice model
Filipa Gouveia, Carla Fonseca, Ana Silva, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111471-111471
Open Access | Times Cited: 6
Filipa Gouveia, Carla Fonseca, Ana Silva, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111471-111471
Open Access | Times Cited: 6
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 6
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 6
Pharmacokinetics of Non-Psychotropic Phytocannabinoids
Mariana Lacerda, Andreia Carona, Sara Castanheira, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Mariana Lacerda, Andreia Carona, Sara Castanheira, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 236-236
Open Access
Association between methylmalonic acid and prevalence of depression in US adults: evidence from NHANES 2011–2014
Siqi Li, Wenbin Nan, Zhenyu Peng, et al.
European journal of psychotraumatology (2025) Vol. 16, Iss. 1
Open Access
Siqi Li, Wenbin Nan, Zhenyu Peng, et al.
European journal of psychotraumatology (2025) Vol. 16, Iss. 1
Open Access
Phytomolecules as Alzheimer’s Therapeutics: A Comprehensive Review
Mohd Kamil Hussain, Mafaz Ahmad, Shahnaaz Khatoon, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117401-117401
Closed Access
Mohd Kamil Hussain, Mafaz Ahmad, Shahnaaz Khatoon, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117401-117401
Closed Access
How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies
Jonasz Dragon, Ewa Obuchowicz
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 4511-4536
Closed Access | Times Cited: 4
Jonasz Dragon, Ewa Obuchowicz
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 4511-4536
Closed Access | Times Cited: 4
Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer’s Disease Neurodegeneration
Long Chen, Haopeng Sun, Jinran Li, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2672-2672
Open Access | Times Cited: 9
Long Chen, Haopeng Sun, Jinran Li, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2672-2672
Open Access | Times Cited: 9
Cannabinoid Modulation of Monoamine Levels in Mouse Brain: Unveiling Neurochemical Dynamics through an Innovative High-performance Liquid Chromatography-Fluorescence Detection Bioanalysis
Carla Fonseca, Susana Cunha, Nuno R. Ferreira, et al.
Journal of Analysis and Testing (2024) Vol. 8, Iss. 3, pp. 300-314
Open Access | Times Cited: 1
Carla Fonseca, Susana Cunha, Nuno R. Ferreira, et al.
Journal of Analysis and Testing (2024) Vol. 8, Iss. 3, pp. 300-314
Open Access | Times Cited: 1
Gut Microbiota-Mediated Alterations of Hippocampal CB1R Regulating the Diurnal Variation of Cognitive Impairment Induced by Hepatic Ischemia–Reperfusion Injury in Mice
Zhigang He, Yanbo Liu, Zhen Li, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 2165-2178
Closed Access | Times Cited: 1
Zhigang He, Yanbo Liu, Zhen Li, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 2165-2178
Closed Access | Times Cited: 1
Análise terapêutica do canabidiol para o tratamento de Alzheimer
Maria Vitória Frota Magalhães, Ruymara Candal Nogueira, Joana Baschung Bertazzon, et al.
Research Society and Development (2024) Vol. 13, Iss. 2, pp. e6513245006-e6513245006
Open Access
Maria Vitória Frota Magalhães, Ruymara Candal Nogueira, Joana Baschung Bertazzon, et al.
Research Society and Development (2024) Vol. 13, Iss. 2, pp. e6513245006-e6513245006
Open Access
Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?
Sónia C. Correia, George Perry, Paula I. Moreira
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S363-S385
Closed Access
Sónia C. Correia, George Perry, Paula I. Moreira
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S363-S385
Closed Access
Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease
Joan Biel Rebassa, Toni Capó, Jaume Lillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5378-5378
Open Access
Joan Biel Rebassa, Toni Capó, Jaume Lillo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5378-5378
Open Access
